Yues International Holdings Group Limited (HK:1529) has released an update.
Yues International Holdings Group Limited has announced a change in the allocation of its unutilized HK$14 million net proceeds, originally intended for the development of the Chinese Medicine Business, now expanded to include general working capital. The adjustment, set to be utilized by December 31, 2025, comes in response to the challenging economic climate in the PRC, including price pressures, rising costs, and intense competition in the TCM industry. This strategic move aims to enhance financial flexibility and ensure liquidity in response to the volatile business environment.
For further insights into HK:1529 stock, check out TipRanks’ Stock Analysis page.
